|
CCDC120 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.69793085042147E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.86568596314419E-12 |
| Normal-vs-Stage2 |
1.142050E-02 |
| Normal-vs-Stage3 |
4.4956000000429E-07 |
| Normal-vs-Stage4 |
2.52249999999066E-06 |
| Stage1-vs-Stage2 |
1.401820E-01 |
| Stage1-vs-Stage3 |
4.634800E-01 |
| Stage1-vs-Stage4 |
9.541400E-01 |
| Stage2-vs-Stage3 |
3.862800E-01 |
| Stage2-vs-Stage4 |
2.213800E-01 |
| Stage3-vs-Stage4 |
5.607200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.83750800633698E-12 |
| Normal-vs-AfricanAmerican |
1.167300E-04 |
| Normal-vs-Asian |
5.37879999984447E-07 |
| Caucasian-vs-AfricanAmerican |
8.260600E-01 |
| Caucasian-vs-Asian |
1.653780E-01 |
| AfricanAmerican-vs-Asian |
4.845800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.9420003906705E-10 |
| Normal-vs-Female |
5.8082982867802E-11 |
| Male-vs-Female |
4.216600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.4309447484211E-12 |
| Normal-vs-Age(41-60Yrs) |
4.648299523069E-10 |
| Normal-vs-Age(61-80Yrs) |
6.220500E-04 |
| Normal-vs-Age(81-100Yrs) |
8.281900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.314600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.012130E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.755400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.102500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.339600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.719800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.387100E-04 |
| Classical-VS-Follicular |
5.17039966396737E-10 |
| Classical-VS-Other |
7.055000E-01 |
| Classical-VS-Normal |
1.62481139653892E-12 |
| Tall-VS-Follicular |
4.678300E-02 |
| Tall-VS-Other |
4.782200E-01 |
| Tall-VS-Normal |
8.613300E-04 |
| Follicular-VS-Other |
1.087430E-01 |
| Follicular-VS-Normal |
2.806000E-01 |
| Other-VS-Normal |
1.000180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.22039999994605E-07 |
| Normal-vs-N1 |
6.44160000007332E-07 |
| N0-vs-N1 |
2.681200E-01 |
|
|
